COPD (Chronic Obstructive Pulmonary Disease) |
COPD |
Clinical Trial: Genetic Epidemiology of COPD in Costa Rica
This study is not yet open for patient recruitment.
Purpose
To examine genetic factors that influence the development of chronic obstructive pulmonary disease (COPD) in Hispanics.
| Condition |
|---|
| Chronic Obstructive Pulmonary Disease Lung Diseases, Obstructive |
MedlinePlus related topics: COPD (Chronic Obstructive Pulmonary Disease)
Study Type: Observational
Study Design: Natural History
Study start: February 2005; Expected completion: March 2010
DESIGN NARRATIVE: The study will examine the genetic factors that influence the development of chronic obstructive pulmonary disease (COPD) in Hispanics, a minority group at high risk for the disease. The study concentrates on a genetically isolated Hispanic population with a high prevalence of COPD living in the Central Valley of Costa Rica. To identify regions of the genome likely to contain genetic determinants of COPD-related phenotypes in this population, the study uses a design that entails collection of phenotypic and genotypic data on 30 large families of probands with moderate to severe COPD that have multiple individuals affected with smoking-related airflow obstruction, comprising 900 individuals from descendants of the Costa Rican Central Valley founder population. A genome scan will be conducted on these large pedigrees using short-tandem repeat (STR) markers and linkage analysis will be performed on six COPD-related phenotypes: chronic bronchitis; airflow obstruction; FEV1; FEV1/FVC; bronchodilator responsiveness; and total serum IgE. Within genomic regions demonstrating linkage to COPD-related phenotypes in the genome scan, narrowly spaced STR markers will be genotyped and tested for linkage between these markers and COPD-related phenotypes. Within selected genomic regions, the association will be tested between single nucleotide polymorphisms (SNPs) in candidate genes and COPD-related phenotypes. By utilizing a family-based study design with a large sample size in a genetically isolated population, the research should be able to address an important yet unstudied problem: the genetic influences on the expression of the COPD phenotype in Hispanics.
Eligibility
Ages Eligible for Study: 21 Years - 60 Years, Genders Eligible for Study: Both
Criteria
Location Information
Juan Celedon, Brigham and Women's Hospital
More Information
Record last reviewed: March 2005
Last Updated: March 24, 2005
Record first received: March 24, 2005
ClinicalTrials.gov Identifier: NCT00106470
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- American Lung Association
- Around the Clock with COPD (American Lung Association)

Not Signed In -


